Company Quick10K Filing
PDL Biopharma
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-11
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-15
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-03
10-Q 2017-03-31 Filed 2017-05-03
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-02-23
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-02-23
10-Q 2014-09-30 Filed 2014-11-10
10-Q 2014-06-30 Filed 2014-08-18
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-03
10-Q 2013-09-30 Filed 2013-11-06
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-02
10-Q 2012-03-31 Filed 2012-05-03
10-K 2011-12-31 Filed 2012-02-23
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-07-29
10-Q 2011-03-31 Filed 2011-04-28
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-07-29
10-Q 2010-03-31 Filed 2010-04-30
10-K 2009-12-31 Filed 2010-03-01
8-K 2020-07-30 Enter Agreement, Other Events, Exhibits
8-K 2020-07-28 Officers
8-K 2020-07-17 Earnings, Regulation FD, Exhibits
8-K 2020-06-29 Other Events, Exhibits
8-K 2020-06-23
8-K 2020-05-21
8-K 2020-05-18
8-K 2020-05-07
8-K 2020-05-05
8-K 2020-05-04
8-K 2020-03-11
8-K 2020-03-09
8-K 2020-02-28
8-K 2020-01-15
8-K 2019-12-23
8-K 2019-12-19
8-K 2019-12-16
8-K 2019-12-13
8-K 2019-12-09
8-K 2019-11-18
8-K 2019-11-14
8-K 2019-11-06
8-K 2019-10-21
8-K 2019-10-03
8-K 2019-09-17
8-K 2019-09-13
8-K 2019-09-11
8-K 2019-08-29
8-K 2019-08-19
8-K 2019-08-07
8-K 2019-06-25
8-K 2019-06-24
8-K 2019-06-10
8-K 2019-05-21
8-K 2019-05-09
8-K 2019-04-16
8-K 2019-04-11
8-K 2019-04-10
8-K 2019-04-08
8-K 2019-03-18
8-K 2019-03-14
8-K 2019-03-12
8-K 2019-03-04
8-K 2019-01-07
8-K 2018-12-21
8-K 2018-11-29
8-K 2018-11-27
8-K 2018-11-06
8-K 2018-10-09
8-K 2018-10-04
8-K 2018-10-02
8-K 2018-09-24
8-K 2018-09-05
8-K 2018-08-08
8-K 2018-08-02
8-K 2018-06-22
8-K 2018-06-14
8-K 2018-06-12
8-K 2018-06-11
8-K 2018-06-08
8-K 2018-06-05
8-K 2018-05-22
8-K 2018-05-21
8-K 2018-05-09
8-K 2018-04-16
8-K 2018-04-09
8-K 2018-04-09
8-K 2018-03-13
8-K 2018-03-08
8-K 2018-02-21
8-K 2018-02-20

PDL Biopharma Financials

PDLI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Agenus (AGEN) 369 0% -2.3 -74% 175 374 122 0 -130 -125 290
Adverum Biotechnologies (ADVM) 350 0% -4.6 -30% 206 41 0 0 -61 -60 276
BioCryst Pharmaceuticals (BCRX) 350 65% -3.0 -148% 90 132 12 8 -134 -124 369
CASI (CASI) 320 5% -7.9 -30% 109 8 3 0 -33 -33 257
CEL-SCI (CVM) 317 -10.2 -111% 28 22 0 0 -31 -30 309
Scholar Rock Holding (SRRK) 311 0% -7.2 -21% 189 67 13 0 -39 -39 278
Gritstone Oncology (GRTS) 302 0% -2.3 -40% 209 52 5 0 -84 -81 184
Eiger Biopharmaceuticals (EIGR) 279 -3.9 -44% 120 48 0 0 -53 -51 199
ADMA Biologics (ADMA) 273 -82% -7.3 -37% 138 102 21 -18 -51 -41 298
PDL Biopharma (PDLI) 265 19% -2.3 0% 865 228 106 20 1 13 -29
La Jolla Pharmaceutical (LJPC) 252 90% -1.6 -61% 149 184 16 14 -91 -91 146
Sutro Biopharma (STRO) 248 0% -6.2 -25% 172 62 51 0 -42 -39 241
Gamida Cell (GMDA) 245 0% 65 0 0 0 0 241
LogicBio Therapeutics (LOGC) 227 -7.0 -43% 67 14 0 0 -29 -28 198
Cellular Biomedicine (CBMG) 191 60% -3.5 -43% 105 38 0 0 -46 -41 145
DBV Technologies (DBVT) 173 0% 172 0 0 0 0 96
Biotime (BTX) 159 62% 3.7 24% 133 17 3 2 32 33 123
Novavax (NVAX) 152 0% -0.6 -91% 165 355 16 0 -150 -135 76
Compugen (CGEN) 149 0% 53 16 0 0 0 0 143
Acorda Therapeutics (ACOR) 148 77% -0.1 -37% 880 599 211 163 -329 -287 28

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash21120021212716815716914118513313118225132094334215282291417292228219291116107147314349510527405396401395366285294
Accounts Receivable00000010001012100001032640311622161813
Inventory2341112914151319161621
PP&E0000009000900090009000900091981989918777
Assets2722583172492842712692352602502803134014305448539169809621,1149961,0211,0161,0551,0491,2161,2151,2381,3021,2241,2431,100946984964924890865
Accounts Payable013000100111010001011001177181010201011913121513
Long-Term Debt155,250155,250429433400335410477246276150150
Liabilities706562641620578514474479421365348406403377430650620578502662468425320313311462460475483401397257233245234230225228
Stockholders' Equity-435-305-324-371-294-243-204-244-161-115-68-94-153113202297402460452527596696743739750751759819823846730693665637
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue120867683122847377126858692144971101401631651171501381251781032154664514463683947684539-2344
Cost of Revenue1235618111512131215
Gross Profit12843139575028325626-3529
R&D222411111114
SG&A911126445756878885761887813107101315151716172017131314
Tax3423-12243825172240462329424638435447355245416233314-4754591310300
Net Income5040-2445704639407449495394566173921025584786910156414-1076021222-11226167-4-18
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3130-13-75213451810536525411046619254776972847570932-9164616-4-17-14-685-13-5
Cash Investing-14-10-30-2-0916-44-3218-2043-340-50-13132111-4-901412-169-11212944251352117-213-4230
Cash Financing-27-9-41-58-47-42-46-68-44-21-21-21-2153198-43-42-7053-205-50-93-33-8-013-8-25-87-0-130-20-1-45-27-16